The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Distinct immunogenomic properties of melanomas with stable disease as best response to immune checkpoint blockade (ICB).
 
Natalie Vokes
No Relationships to Disclose
 
Claire Margolis
No Relationships to Disclose
 
David Liu
No Relationships to Disclose
 
Bastian Schilling
Honoraria - Bristol-Myers Squibb; Incyte; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Incyte; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Pierre Fabre (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Pierre Fabre; Roche
 
Dirk Schadendorf
Honoraria - 4SC; Agenus; Amgen; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Grunenthal; Immunocore; Incyte; LEO Pharma; Merck Serono; Merck Sharp & Dohme; Mologen; Novartis; Pfizer; Philogen; Pierre Fabre; Regeneron; Roche/Genentech; Sysmex
Consulting or Advisory Role - 4SC; Amgen; Bristol-Myers Squibb; Immunocore; Incyte; Merck Serono; Merck Sharp & Dohme; Mologen; Novartis; Pierre Fabre; Roche/Genentech; Sanofi/Regeneron
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Incyte; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; Merck Serono; Novartis; Roche/Genentech
 
Eliezer Mendel Van Allen
Stock and Other Ownership Interests - Genome Medical; Microsoft; Syapse; Tango Therapeutics
Consulting or Advisory Role - Dynamo Therapeutics; Forest Laboratories/Actavis; Genome Medical; Illumina; InVitae; Novartis; Roche; Syapse; Takeda; Tango Therapeutics; Third Rock Ventures
Speakers' Bureau - Illumina
Research Funding - Bristol-Myers Squibb; Novartis
Patents, Royalties, Other Intellectual Property - Patent on discovery of chromatin regulators as biomarkers of response to cancer immunotherapy (Inst); Patent on discovery of retained intron as source of cancer neoantigens (Inst)
Travel, Accommodations, Expenses - Roche/Genentech